Do changes in weight status affect cognitive function in children and adolescents with obesity? A secondary analysis of a clinical trial.

BMJ Open 2019 02 19;9(2):e021586. Epub 2019 Feb 19.

Liggins Institute, University of Auckland, Auckland, New Zealand.

Objectives: It is unclear whether an association exists between obesity in children/adolescents and cognitive function, and whether the latter can be altered by body mass index (BMI) standard deviation score (SDS) reductions. We aimed to determine whether an association exists between BMI SDS and cognitive function in children/adolescents with obesity engaged in an obesity intervention. Second, we sought to determine if BMI SDS reduction at 12 months was associated with improved cognitive function.

Design: Secondary analysis of a clinical trial.

Participants: Participants (n=69) were recruited from an obesity intervention. Eligible participants (recruited June 2013 to June 2015) were aged 6-16 years, with a BMI ≥98th centile or BMI >91st centile with weight-related comorbidities.

Outcome Measures: Primary outcome measure was change in BMI SDS from baseline at 12 months. Dependent variables of cognitive functioning and school achievement were assessed at baseline and 12 months, using dependent variables of cognitive functioning (elements of Ravens Standard Progressive Matrices, Wide Range Achievement Test-fourth edition and Wechsler Intelligence Scale for Children-fourth edition).

Results: At baseline, BMI SDS was not associated with all aspects of cognitive function tested (n=69). Reductions in BMI SDS over time did not alter cognitive function overall. However, there was a greater reduction in comprehension standard scores in participants who increased their BMI SDS (adjusted estimated difference -6.1, 95% CI -11.6 to -0.6; p=0.03).

Conclusions: There were no observed associations between BMI SDS and cognitive function in participants, apart from comprehension in the exploratory analyses, which may have been a random finding. Further studies need to include larger longitudinal cohorts incorporating a wider BMI range at entry to determine whether our findings persist.

Trial Registration Number: ANZCTR12611000862943; Pre-results.

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmjopen-2018-021586DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367974PMC
February 2019
Save 15% Survey

Similar Publications

Ultrasonographic determination of thyroid volume in infants and children from Aegean region of Turkey and comparison with national and international references.

J Pediatr Endocrinol Metab 2021 Feb 24. Epub 2021 Feb 24.

Department of Radiology, University of Health Sciences Dr. Behçet Uz Child Disease and Pediatric Surgery Training and Research Hospital, Izmir, Turkey.

Objectives: Accurate diagnosis and follow-up of pediatric patients with thyroid disorders, depends on the availability of appropriate data for normal thyroid volume (TV). The aim of this study was to determine the TV by ultrasonography (US) in subjects from the newborn period up to 18 years of age from the Aegean region of Turkey.

Methods: We measured the thyroid volumes in 513 children using US and compared them with the children's age, gender, standard deviation score (SDS) of body height (BH-SDS), body weight (BW-SDS), body mass index (BMI-SDS), and body surface area (BSA-SDS). Read More

View Article and Full-Text PDF
February 2021

High Prevalence of Weight Gain in Childhood Brain Tumor Survivors and Its Association With Hypothalamic-Pituitary Dysfunction.

J Clin Oncol 2021 Feb 23:JCO2001765. Epub 2021 Feb 23.

Department of Pediatric Endocrinology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands.

Purpose: Childhood brain tumor survivors (CBTS) are at risk for developing obesity, which negatively influences cardiometabolic health. The prevalence of obesity in CBTS may have been overestimated in previous cohorts because of inclusion of children with craniopharyngioma. On the contrary, the degree of weight gain may have been underestimated because of exclusion of CBTS who experienced weight gain, but were neither overweight nor obese. Read More

View Article and Full-Text PDF
February 2021

Endocrine dysfunction in children with Shwachman-Diamond syndrome.

Endokrynol Pol 2021 Feb 23. Epub 2021 Feb 23.

Department of Endocrinology and Diabetology, The Children's Memorial Health Institute, Av. Dzieci Polskich 20, 04-736 Warsaw, Poland.

Introduction Shwachman-Diamond syndrome (SDS) is a rare autosomal recessive disorder characterized by pancreatic exocrine insufficiency, immune deficiency, bone marrow failure and bone malformations. Systematic data concerning endocrine function in SDS are limited. We studied patients diagnosed in The Children's Memorial Health Institute in Warsaw, Poland, to assess the prevalence of various endocrinopathies. Read More

View Article and Full-Text PDF
February 2021

Gonadotropin releasing hormone analogue therapy in girls with idiopathic precocious puberty/early-fast puberty: dynamics in adiposity indices, eating habits and quality of life.

J Pediatr Endocrinol Metab 2021 Feb 22. Epub 2021 Feb 22.

Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Background: The impact of gonadotropin-releasing-hormone-analogue (GnRHa) treatment on weight and body composition is controversial. Exploring the nutritional, psychological patterns of this population may aid to clarify this propensity to gain weight. This prospective observational study aimed to evaluate longitudinal changes in adiposity, nutrition and quality of life in girls with central precocious/early-fast puberty (CPP/EFP) during GnRHa treatment. Read More

View Article and Full-Text PDF
February 2021

Fasting plasma GLP-1 associates with overweight/obesity and cardiometabolic risk factors in children and adolescents.

J Clin Endocrinol Metab 2021 Feb 17. Epub 2021 Feb 17.

The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Context: The importance of fasting GLP-1 in altered metabolic outcomes has been questioned.

Objective: To assess if fasting GLP-1 differs in children and adolescents with overweight/obesity compared to a population-based reference, and whether concentrations predict cardiometabolic risk (CMR) factors.

Methods: Analyses were based on The Danish Childhood Obesity Data- and Biobank, a cross-sectional study including children and adolescents, 6-19 years old, from an obesity clinic group (n = 1978) and from a population-based group (n = 2334). Read More

View Article and Full-Text PDF
February 2021